Spatial transcriptome profiling links SERPINA3 to nerve-associated immunosuppression in pancreatic cancer
- 10 July 2026
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 830, 154222
Abstract
No abstract availableKeywords
Funding Information
- Beijing Nova Program
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
This publication has 21 references indexed in Scilit:
- Altered somatostatin receptor 3 expression and functional dysregulation in tuberous sclerosis complexProgress in Neurobiology, 2025
- Cancer neuroscience: State of the field, emerging directionsCell, 2023
- Cancer hallmarks intersect with neuroscience in the tumor microenvironmentCancer Cell, 2023
- Unfolding the cascade of SERPINA3: Inflammation to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancerCancer Cell, 2022
- Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesThe Lancet Oncology, 2022
- Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in gliomaImmunity, Inflammation and Disease, 2021
- Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingNature Communications, 2021
- Roadmap for the Emerging Field of Cancer NeuroscienceCell, 2020
- Granzyme B: pro-apoptotic, antiviral and antitumor functionsCurrent Opinion in Immunology, 2003